Aastrom Biosciences, Inc. to Host Third Quarter 2013 Investor Call on November 12, 2013
Published: Nov 08, 2013
ANN ARBOR, Mich., Nov. 7, 2013 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, announces the following webcast:
Help employers find you! Check out all the jobs and post your resume.